You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
Using Immunoassay technique to determine clinical efficacy of a biosimilar Filgrastim with reference Filgrastim
- In: Poster Presentation
- At: Stockholm (Sweden) (2017)
- Type: Poster
- Poster code: P-D-016-Monday
- By: ABOTALEB, Abdalla (Ministry of health, post marketing survillance, cairo, Egypt)
- Co-author(s): Nahla kotb: Lot release, NORCB, cairo, Egypt
Abdalla Abotaleb: post marketing survillance, NORCB, cairo, Egypt
Doaa Mohamed: Lot release, NORCB, cairo, Egypt - Abstract:
Backgrounds
Over the next few years, the field of Biosimilars is expected to rapidly expand with the imminent patent expiry of a number of important biopharmaceuticals. Which raise a questionHow regulatory body use a simple, accurate, effective technique to Guarantee safety and efficacy of Biosimilars products?
Aims
Conducting methods can help.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026